In the first quarter, Zibo City’s chemical, metallurgical and pharmaceutical industries maintained rapid growth.
Time:2019-03-22
[Gade Chemical Network Enterprise News] In the first quarter, the added value of industrial enterprises above designated size increased by 7.86% year-on-year, an increase of 0.46 percentage points over the same period of last year. Chemical, metallurgical, pharmaceutical and other industries have grown rapidly.
The chemical raw materials and chemical products manufacturing industry was affected by the sharp drop in crude oil prices. The raw material prices fell, the production costs of enterprises declined, and the profits of some enterprises increased. Dongyue Group's green environmentally friendly refrigerants entered the peak season of sales, and demand continued to pick up. The main business income increased by nearly 20%, and profits and taxes and profits increased substantially, with an increase of more than 200%. The petroleum processing industry was affected by the downturn of international crude oil, and the price of the products declined, but the overall operation situation was good. The growth rate of the main business income of Qilu Petrochemical and Jincheng Petrochemical Company remained at around 30%; the non-ferrous metal smelting and rolling processing industry was driven by the rebound of product prices, and the production enthusiasm was high, production accelerated, and inventory was low. Chinalco Shandong Branch achieved a 75% increase in its main business income and a profit of 146 million yuan, turning losses into profits. The ferrous metal mining and mining industry and the smelting and rolling processing industry steel prices rose first and then fell. In March, with the construction site started to recover, the market demand improved, the overall better than the same period last year; the pharmaceutical industry is stable and growing rapidly. Shandong Xinhua Pharmaceutical Group achieved a revenue growth of nearly 30% in its main business; its profit increased by nearly 130%. Shandong Xinhua Medical Machinery Group achieved a revenue growth of over 30% in its main business.
